Y Intercept (Hong Kong) LTD Arcturus Therapeutics Holdings Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $3.75 Billion
- Q2 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 44,432 shares of ARCT stock, worth $525,630. This represents 0.02% of its overall portfolio holdings.
Number of Shares
44,432
Previous 23,077
92.54%
Holding current value
$525,630
Previous $244,000
136.89%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding ARCT
# of Institutions
162Shares Held
26.1MCall Options Held
312KPut Options Held
96.5K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$55.5 Million0.11% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$31.3 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.1.93MShares$22.8 Million0.27% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.83MShares$21.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$20.7 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $314M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...